
Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations

I'm PortAI, I can summarize articles.
Lite Strategy, Inc. reported its first quarter fiscal year 2026 results, highlighting the successful launch of a $100M Litecoin treasury strategy. The company rebranded from MEI Pharma to Lite Strategy, adopting Litecoin as its primary reserve asset. It entered a strategic partnership with GSR and announced a $25M share repurchase program. As of September 30, 2025, Lite Strategy had $12.21M in working capital with no debt, marking its move into active capital market operations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

